EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Hyperbaric Oxygen Therapy as a Sole Agent Is Not Immunosuppressant in a Highly Immunogenic Mouse Model

Adam Gassas, Weixian Min, A Wayne Evans, Susan Carter, George K Sándor, Eyal Grunebaum

Bone Marrow Research · 03.08.2011 · 2011 · 1-3

DOI: 10.1155/2011/579268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone Marrow Research, erschienen am 03.08.2011. Verfasst von Adam Gassas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology/Oncology/BMT, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperbaric oxygen (HBO) therapy, which is used for many conditions, may also have immunosuppressive effects and could be used for prevention or treatment of graft-versus-host disease (GvHD). If HBO is immunosuppressant, then we hypothesize that HBO therapy will delay the T-cell mediated skin graft rejection.

Methods

C57/BL6 black-coated (H2B) mice received skin graft from CBA (H2D) white-coated mice. Mice were treated with either 19 session of 240 kpa oxygen or 29 session of 300 kpa oxygen, for 90 minutes. Mice were housed either 4 per cage or separately, to prevent friction and mechanical factors that may affect graft survival. Skin grafts were assessed daily.

Results

There was no difference in length of graft survival between mice that received either regimens of HBO therapy and mice that did not receive HBO therapy.

Conclusions

HBO therapy, as a sole agent, did not delay skin graft rejection in a highly immunogenic mouse model.

Autor:innen und Institutionen

  • Division of Haematology/Oncology/BMT, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, Canada M5G 1X8.

Zitieren

APA

Gassas, A., Min, W., Evans, A. W., Carter, S., Sándor, G. K., & Grunebaum, E. (2011). Hyperbaric Oxygen Therapy as a Sole Agent Is Not Immunosuppressant in a Highly Immunogenic Mouse Model. Bone Marrow Research, 2011, 1-3. https://doi.org/10.1155/2011/579268

Vancouver

Gassas A, Min W, Evans AW, Carter S, Sándor GK, Grunebaum E. Hyperbaric Oxygen Therapy as a Sole Agent Is Not Immunosuppressant in a Highly Immunogenic Mouse Model. Bone Marrow Research. 2011;2011:1-3. doi:10.1155/2011/579268

BibTeX
@article{Gassas2011,
  author = {Gassas, Adam and Min, Weixian and Evans, A Wayne and Carter, Susan and Sándor, George K and Grunebaum, Eyal},
  title = {Hyperbaric Oxygen Therapy as a Sole Agent Is Not Immunosuppressant in a Highly Immunogenic Mouse Model},
  journal = {Bone Marrow Research},
  year = {2011},
  volume = {2011},
  pages = {1--3},
  doi = {10.1155/2011/579268}
}
Kostenlos starten →